Randal Scott W.'s most recent trade in BridgeBio Pharma Inc was a trade of 10,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc | Randal W. Scott | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2026 | 10,000 | 21,501 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.75 per share. | 15 May 2026 | 10,000 | 21,589 (0%) | 0% | 16.8 | 167,500 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 66.69 per share. | 15 May 2026 | 6,200 | 15,389 (0%) | 0% | 66.7 | 413,464 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 67.53 per share. | 15 May 2026 | 2,088 | 13,301 (0%) | 0% | 67.5 | 141,003 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 68.23 per share. | 15 May 2026 | 1,512 | 11,789 (0%) | 0% | 68.2 | 103,164 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 69.12 per share. | 15 May 2026 | 200 | 11,589 (0%) | 0% | 69.1 | 13,824 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.75 per share. | 17 Nov 2025 | 10,000 | 21,589 (0%) | 0% | 16.8 | 167,500 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2025 | 10,000 | 41,501 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 66.89 per share. | 17 Nov 2025 | 6,199 | 11,589 (0%) | 0% | 66.9 | 414,656 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 66.25 per share. | 17 Nov 2025 | 3,801 | 17,788 (0%) | 0% | 66.2 | 251,809 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 8,425 | 8,425 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 6,589 | 11,589 (0%) | 0% | 0 | Common Stock | |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 26,014 | 26,014 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 31.30 per share. | 03 Jun 2024 | 1,500 | 4,000 (0%) | 0% | 31.3 | 46,950 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 28.68 per share. | 03 Jun 2024 | 800 | 5,700 (0%) | 0% | 28.7 | 22,948 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 29.48 per share. | 03 Jun 2024 | 200 | 5,500 (0%) | 0% | 29.5 | 5,895 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 01 Mar 2024 | 2,500 | 6,500 (0%) | 0% | 34 | 85,000 | Common Stock |
| BridgeBio Pharma Inc | Randal Scott W. | Director | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 18 Dec 2023 | 2,000 | 9,000 (0%) | 0% | 40 | 80,000 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 01 Dec 2023 | 1,500 | 11,000 (0%) | 0% | 30 | 45,000 | Common Stock |
| BridgeBio Pharma Inc | W. Scott Randal | Director | Sale of securities on an exchange or to another person at price $ 28.50 per share. | 01 Dec 2023 | 1,000 | 12,500 (0%) | 0% | 28.5 | 28,500 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 51,501 | 51,501 | - | - | Stock Option (right to buy) | |
| Talis Biomedical Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 95,000 | 95,000 | - | - | Stock option (right to buy) | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 86,705 | 86,705 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 70,422 | 161,222 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 28,901 | 28,901 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 45,325 | 82,325 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 22,730 | 22,730 | - | - | Employee Stock Option (right to buy) | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 8,475 | 90,800 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 4,275 | 4,275 | - | - | Employee Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| Talis Biomedical Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 95,000 | 95,000 | - | - | Stock Option (right to buy) |